Rebecca Mcqualter – Biography
Last update: February 23, 2026Executive profile
Rebecca was Head of Strategic Access at Novartis, and Head, Haematology Pipeline Medical at Bioverativ. Rebecca Mcqualter joined Chimeric Therapeutics in 2024. Rebecca served as Chief Operating Officer at Chimeric Therapeutics.
Rebecca Mcqualter is currentlyChief Executive Officer at Chimeric Therapeutics - View - Chimeric Therapeutics org chart
Create your alert
to follow the career of Rebecca Mcqualter.
Education
Rebecca Mcqualter has a PhD in Cell Therapy Regenerative Medicine from Monash University.
They have also studied at Monash University :
Find more alumni from Monash University
More about Rebecca Mcqualter
Selected links
Do you need to know more about Rebecca Mcqualter? More results.
Participate
Social media
- Rebecca Mcqualter on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Rebecca Mcqualter
The colleagues of Rebecca Mcqualter
Company Colleagues
- At Chimeric Therapeutics, Rebecca Mcqualter has 8 colleagues including Phillip Hains (Director), Eric Sullivan (Director)…
Industry Colleagues
- In the Biotechnology industry, Rebecca Mcqualter has 35,756 colleagues in 2,407 companies located in 42 countries. 16,877 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Rebecca Mcqualter.
Get in Touch
Here are a few tips for establishing great contacts.
